Explore All 400 Growth Capital Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | December 9, 2016 |
| Target | OxThera |
| Sector | Life Science |
| Investor(s) | EQT Life Sciences |
| Deal Type | Growth Capital |
FILTER BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| Deal Context for Investor | # |
|---|---|
| Overall | 13 of 47 |
| Sector: Life Science | 6 of 30 |
| Type: Growth Capital | 3 of 5 |
| Country: Sweden | 1 of 1 |
| Year: 2016 | 6 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-09-08 |
Vivasure Medical
Galway, Ireland Vivasure Medical is a medical device company developing advanced polymer implants and delivery systems, primarily focused on minimally invasive vessel closure in cardiology, interventional radiology and vascular surgery. Vivasure Medical was founded in 2009 and is based in Galway, Ireland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-05-02 |
Imcheck Therapeutics
Marseilles, France ImCheck Therapeutics is a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel superfamily of immunomodulators. Its clinical-stage program, ICT01, has been advancing to late-stage trials, demonstrating a unique mechanism of action that modulates both innate and adaptive immunity. These “first-in-class” activating antibodies may deliver superior clinical outcomes compared to first-generation immunotherapy approaches, in particular in rational combinations with immune checkpoint inhibitors and immunomodulatory anti-cancer drugs. Imcheck Therapeutics was founded in 2015 and is based in Marseilles, France. |
Buy | - |
